Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$514.7M+12.2%$564.17M+17.0%$465.22M+2.2%$429.53M-4.2%$458.76M+5.3%
$49.06M+2.0%$44.54M-11.4%$45.79M-9.4%$42.91M-15.3%$48.1M+4.6%
$318.91M+8.2%$326.24M+10.8%$299.92M+6.3%$291.97M+6.4%$294.7M+9.9%
$512.16M+6.1%$519.48M+14.3%$473.59M-8.5%$452.39M-6.4%$482.94M+14.8%
$139.57M+26.0%$137.52M+18.8%$118.66M+6.6%$109.2M-1.7%$110.77M+2.0%
$2.55M$44.69M
0.5%7.9%
-$1.7M-1,408%-$2.28M-242%-$2.05M-197%-$1.16M-156%$130K-93.7%
$1.73M+1,764%$2.28M+246%$2.14M+203%$1.29M+162%-$104K+94.8%
$4.28M$46.97M
$1.56M$9.94M
$2.72M+117%$37.03M+4,201%$1.01M-$8.23M-$15.88M
0.5%+4.0pp6.6%+6.4pp0.2%-1.9%-3.5%
-$0.16$0.11
$18.55M$59.97M
3.6%10.6%
$2.55M$44.69M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Organogenesis Holdings Inc.'s revenue?
Organogenesis Holdings Inc. (ORGO) generated $514.7M in revenue over the trailing twelve months, up 12.2% year over year.
Is Organogenesis Holdings Inc. profitable?
Organogenesis Holdings Inc. reported $2.7M in net income over the trailing twelve months, a 0.5% net margin.
What are Organogenesis Holdings Inc.'s profit margins?
Gross margin is 75.9% and operating margin is 0.5%, with a 0.5% net margin.
What is Organogenesis Holdings Inc.'s earnings per share?
Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.16.
Where does Organogenesis Holdings Inc.'s income statement data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.